Trial Profile
Pharmacogenomics Study of CPT-11 as the First-line Chemotherapy for mCRC.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Aug 2014
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Biomarker; Pharmacogenomic; Therapeutic Use
- Sponsors Pfizer
- 24 Jul 2014 According to the Chinese Clinical Trial Register, status changed from not yet recruiting to completed.
- 25 Feb 2011 New trial record